AUG 12, 2021 5:00 PM PDT

Postpartum depression drug works through altering brain waves

WRITTEN BY: J. Bryce Ortiz

Postpartum depression is a form of depression that occurs after childbirth. This form of depression can be severe and life-threatening and may lead to the development of major depressive disorder later in life. Past treatment for postpartum depression has relied on antidepressants, mood stabilizers, or a form of cognitive behavioral therapy. However, the recent approval of allopregnanolone is important for the treatment of postpartum depression as it has long-lasting effects in reducing depression. 

Allopregnanolone, also known as brexanolone (trade name Zulresso), is currently the only FDA approved drug that is marketed specifically to treat postpartum depression and was approved by the FDA in March of 2019. At the time of approval, allopregnanolone’s beneficial effects on postpartum depression were linked to the drug’s action as a positive allosteric modulator of the GABAA receptor. However, allopregnanolone is also neurosteroid. And despite the well-known mechanisms of action of neurotsteriods and GABAA modulators, the exact mechanism by which allopregnanolone exerts its antidepressant effects remained unclear. In a recent study published in the Journal Biological Psychiatry, researchers used electroencephalogram (EEG) recordings and behavioral tests to understand how the drug leads antidepressant effects. 

The researchers utilized EEG recordings in humans and rats to show that allopregnanolone altered brain waves. They found an increase in the power of the delta, theta, beta, and alpha frequency waves when humans were administered allopregnanolone which is indicative of anti-depressant actions. A similar finding occurred in the EEG recordings of rats as well. Because of these similarities between rodents and humans, the researchers were then able to assess the brains of the rodents to continue to tease apart the mechanisms by which allopregnanolone exerts its action. To this end, they found that specific inhibitory neurons in a brain region called the amygdala were, in part, responsible for facilitating these positive increases in brain wave frequencies. 

These data help to demonstrate a previously undiscovered mechanism by which allopregnanolone effectively treats postpartum depression. Additionally, the data can help to guide future research and drug discovery for the treatment of different forms of depression, including treatment resistant depression. 

Sources: Mayo ClinicLabrootsBiological Psychiatry

About the Author
PhD in Neuroscience
Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
JUL 20, 2022
Neuroscience
Stress Transmitter Wakes Up the Sleeping Brain Over 100 Times Per Night
JUL 20, 2022
Stress Transmitter Wakes Up the Sleeping Brain Over 100 Times Per Night
A study published in Nature Neuroscience reported that the stress hormone and transmitter noradrenaline wakes up the hum ...
AUG 12, 2022
Technology
Bioengineered Cornea Helps Restore Sight for the Visually Impaired
AUG 12, 2022
Bioengineered Cornea Helps Restore Sight for the Visually Impaired
Corneal disease refers to a range of conditions that can cause significant damage to the cornea, the clear tissue layer ...
AUG 15, 2022
Drug Discovery & Development
Electrical Stimulation of Eyes Improves Symptoms of Alzheimer's, Depression
AUG 15, 2022
Electrical Stimulation of Eyes Improves Symptoms of Alzheimer's, Depression
Electrical stimulation of the eye's surface may alleviate depression-like symptoms and improve cognitive function in ...
AUG 30, 2022
Clinical & Molecular DX
Caffeine Metabolite Could Slow Progression of Nearsightedness in Children
AUG 30, 2022
Caffeine Metabolite Could Slow Progression of Nearsightedness in Children
Myopia, also known as nearsightedness, is a common vision condition in which objects far away appear blurry. Myopia occu ...
SEP 27, 2022
Clinical & Molecular DX
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
SEP 27, 2022
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
In advanced stages of skin cancer, patients develop brain metastases about 90% of the time. Though this is one of the mo ...
SEP 26, 2022
Drug Discovery & Development
Respiratory Syncytial Virus Antigens and Antibodies
SEP 26, 2022
Respiratory Syncytial Virus Antigens and Antibodies
In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial v ...
Loading Comments...